IN THIS LESSON
Established Safety Record
Transcranial photobiomodulation has demonstrated an exceptional safety profile across multiple clinical trials totaling over 1,400 patients in stroke studies alone, with additional hundreds of participants in dementia, TBI, depression, and other neurological condition trials. The NEST (NeuroThera Effectiveness and Safety Trials) series, which included three large studies (NEST-1 n=120, NEST-2 n=660, NEST-3 n=630), found no significant differences in rates of adverse events between NIR light treatment and sham exposure.
Common minor side effects reported include mild headaches, perception of vivid colors, transient irritability, unusual tastes in the mouth, and occasional mild dizziness likely from peripheral vasodilatory effects. These effects are typically mild, transient, and resolve without intervention. Long-term follow-up studies have reported no serious adverse effects, delayed complications, or safety concerns even with daily administration for 12 weeks.
The non-thermal nature of low-level laser therapy is critical to its safety profile. At the power densities employed (typically <400 mW/cm²), tissue heating is negligible and produces no physical damage. Studies using thermography and computational modeling confirm that the effects are photobiochemical rather than thermal.
-
Citations:
Henderson TA, Morries LD. Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain? Neuropsychiatr Dis Treat. 2015;11:2191-2208.
Morries LD, Cassano P, Henderson TA. Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy. Neuropsychiatr Dis Treat. 2015;11:2159-75.
Henderson TA, Morries LD. Multi-watt near-infrared phototherapy for the treatment of comorbid depression: An open-label single-arm study. Front Psychiatry. 2017;8:187.
Shen Q, Guo H, Yan Y. Photobiomodulation for neurodegenerative diseases: A scoping review. Int J Mol Sci. 2024;25:1625.
Moro C, Valverde A, Dole M, et al. The effect of photobiomodulation on the brain during wakefulness and sleep. Front Neurosci. 2022;16:942536.
Hamblin MR. Shining light on the head: Photobiomodulation for brain disorders. BBA Clin. 2016;6:113-124.
Lapchak PA, Boitano PD, Butte PV, et al. Transcranial near-infrared laser transmission (NILT) profiles: Systematic comparison in four common research species. PLoS ONE. 2015;10:e0127580.
Cassano P, Petrie SR, Hamblin MR, et al. Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis. Neurophotonics. 2016;3:031404.
Tedford CE, DeLapp S, Jacques S, Anders J. Quantitative analysis of transcranial and intraparenchymal light penetration in human cadaver brain tissue. Lasers Surg Med. 2015;47:312-22.
Barrett DW, Gonzalez-Lima F. Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects in humans. Neuroscience. 2013;230:13-23.
Salehpour F, Rasta SH, Mohaddes G, et al. Therapeutic effects of 10-Hz pulsed wave lasers in rat depression model: A comparison between near-infrared and red wavelengths. Lasers Surg Med. 2016;48:695-705.
Naeser MA, Zafonte R, Krengel MH, et al. Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study. J Neurotrauma. 2014;31:1008-17.
Xuan W, Agrawal T, Huang L, et al. Low-level laser therapy for traumatic brain injury in mice increases brain-derived neurotrophic factor (BDNF) and synaptogenesis. J Biophotonics. 2015;8:502-11.
Johnstone DM, Moro C, Stone J, et al. Turning on lights to stop neurodegeneration: The potential of near-infrared light therapy in Alzheimer's and Parkinson's disease. Front Neurosci. 2016;9:500.
Wang X, Tian F, Reddy DD, et al. Up-regulation of cerebral cytochrome-c-oxidase and hemodynamics by transcranial infrared laser stimulation: A broadband near-infrared spectroscopy study. J Cereb Blood Flow Metab. 2017;37:3789-3802.
